NCT05931835View on ClinicalTrials.gov

Feasibility Study on the VERAFEYE System

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 9, 2025

Primary Completion Date

May 15, 2025

Study Completion Date

May 22, 2025

Conditions
Atrial Septal DefectAtrial FibrillationAtrial ArrhythmiaLeft Atrial Appendage Closure
Interventions
DEVICE

VERAFEYE System

The VERAFEYE System will be used during standard of care, catheter-based treatments for atrial flutter or atrial fibrillation; or left atrial appendage/atrial septal defect closure procedures.

Trial Locations (1)

D07 RD8P

Mater Private Network, Dublin

All Listed Sponsors
lead

LUMA Vision Ltd.

INDUSTRY

NCT05931835 - Feasibility Study on the VERAFEYE System | Biotech Hunter | Biotech Hunter